Lataa...
Zonisamide add‐on therapy for focal epilepsy
BACKGROUND: The majority of people with epilepsy have a good prognosis, and their seizures can be well controlled with the use of a single antiepileptic agent, but up to 30% develop refractory epilepsy, especially those with focal seizures. In this review, we summarised the evidence from randomised...
Tallennettuna:
| Julkaisussa: | Cochrane Database Syst Rev |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley & Sons, Ltd
2018
|
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517010/ https://ncbi.nlm.nih.gov/pubmed/30335200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001416.pub4 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|